Transformed Toxoplasma gondii tachyzoites expressing the circumsporozoite protein of Plasmodium knowlesi elicit a specific immune response in rhesus monkeys

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1677-1682

  Di Cristina, Manlio ^a   Ghouze, Firman ^a   Kocken, Clemens H M ^b   Naitza, Silvia ^a   Cellini, Pamela ^c   Soldati, Dominique ^d   Thomas, Alan W ^b   Crisanti, Andrea ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; NONHUMAN; PLASMODIUM KNOWLESI; PRIORITY JOURNAL; RHESUS MONKEY; SEROCONVERSION; SPOROZOITE; TOXOPLASMA GONDII;

EID: 0033003404     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.67.4.1677-1682.1999     Document Type: Article

References (37)

1. Achbarou, A., O. Mercereau Puijalon, A. Sadak, B. Fortier, M. A. Leriche, D. Camus, and J. F. Dubremetz. 1991. Differential targeting of dense granule proteins in the parasitophorous vacuole of Toxoplasma gondii. Parasitology 3:321-329.
2. Aidoo, M., A. Lalvani, H. C. Whittle, A. V. Hill, and K. J. Robson. 1997. Recombinant vaccinia viruses for the characterization of Plasmodium falciparum-specific cytotoxic T lymphocytes: recognition of processed antigen despite limited re-stimulation efficacy. Int. Immunol. 9:731-737.
3. Allsopp, C. E., M. Plebanski, S. Gilbert, R. E. Sinden, S. Harris, G. Frankel, G. Dougan, C. Hioe, D. Nixon, E. Paoletti, G. Layton, and A. V. Hill. 1996. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 26:1951-1959.
4. Ballou, W. R., S. L. Hoffman, J. A. Sherwood, M. R. Hollingdale, F. A. Neva, W. T. Hockmeyer, D. M. Gordon, I. Schneider, R. A. Wirtz, J. F. Young, et al. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1:1277-1281.
5. Black, M., F. Seeber, D. Soldati, K. Kim, and J. C. Boothroyd. 1995. Restriction enzyme-mediated integration elevates transformation frequency and enables co-transfection of Toxoplasma gondii. Mol. Biochem. Parasitol. 74:55-63.
6. Brown, A. E., P. Singharaj, H. K. Webster, J. Pipithkul, D. M. Gordon, J. W. Boslego, K. Krinchai, P. Suarchawaratana, C. Wongsrichanalai, W. R. Ballou, et al. 1994. Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers. Vaccine 12:102-108.
7. Burg, J. L., D. Perelman, L. H. Kasper, P. L. Ware, and J. C. Boothroyd. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141:3584-3591.
8. Buxton, D., and E. A. Innes. 1995. A commercial vaccine for ovine toxoplasmosis. Parasitology 110:S11-S16.
9. Buxton, D., K. M. Thomson, S. Maley, S. Wright, and H. J. Bos. 1993. Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Vet. Rec. 133:310-312.
10. Chan, S., H. Gabra, F. Hill, G. Evan, and K. Sikora. 1987. A novel tumour marker related to the c-myc oncogene product. Mol. Cell Probes 1:73-82.
11. Dubey, J. P. 1996. Strategies to reduce transmission of Toxoplasma gondii to animals and humans. Vet. Parasitol. 64:65-70.
12. Dubremetz, J. F., A. Achbarou, D. Bermudes, and K. A. Joiner. 1993. Kinetics and pattern of organelle exocytosis during Toxoplasma gondii/host-cell interaction. Parasitol. Res. 79:402-408.
13. Frenkler, J. K. 1988. Pathophysiology of toxoplasmosis. Parasitol. Today 4: 273.
14. Gazzinelli, R. T., E. Y. Denkers, and A. Sher. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect. Agents Dis. 2:139-149.
15. Gerloni, M., W. R. Baliou, R. Billetta, and M. Zanetti. 1997. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Nat. Biotechnol. 15:876-881.
16. Girdwood, R. W. 1989. 'Protozoan' infections in the immunocompromised patient - the parasites and their diagnosis. J. Med. Microbiol. 30:3-16.
17. Godson, G. N., J. Ellis, P. Svec, D. H. Schlesinger, and V. Nussenzweig. 1983. Identification and chemical synthesis of a tandemly repeated immunogenic region of Plasmodium knowlesi circumsporozoite protein. Nature 305:29-33.
18. Gramzinski, R. A., D. C. Maris, D. Doolan, Y. Charoenvit, N. Obaldia, R. Rossan, M. Sedegah, R. Wang, P. Hobart, M. Margalith, and S. Hoffman. 1997. Malaria DNA vaccines in Aotus monkeys. Vaccine 15:913-915.
19. Hochuli, E., W. Bannwarth, H. Döbeli, R. Gentz, and D. Stüber. 1988. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology 6:1321-1325.
20. Hoffman, S. L., D. L. Doolan, M. Sedegah, J. C. Aguiar, R. Wang, A. Malik, R. A. Gramzinski, W. R. Weiss, P. Hobart, J. A. Norman, M. Margalith, and R. C. Hedstrom. 1997. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine 15:842-845.
21. Hollingdale, M. R., E. H. Nardin, S. Tharavanij, A. L. Schwartz, and R. S. Nussenzweig. 1984. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells: an in vitro assay of protective antibodies. J. Immunol. 132:909-913.
22. Kim, K., D. Soldati, and J. C. Boothroyd. 1993. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science 262:911-914.
23. Lanar, D. E., J. A. Tine, C. de Taisne, M. C. Seguin, W. I. Cox, J. P. Winslow, L. A. Ware, E. B. Kauffman, D. Gordon, W. R. Ballou, E. Paoletti, and J. C. Sadoff. 1996. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria. Infect. Immun. 64:1666-1671.
24. Levine, N. D. 1988. Progress in taxonomy of the apicomplexan protozoa. J. Protozool. 35:518-520.
25. McGregor, I. A. 1993. Towards a vaccine against malaria. Br. J. Biomed. Sci. 50:35-42.
26. Nussenzweig, R. S., and V. Nussenzweig. 1989. Antisporozoite vaccine for malaria: experimental basis and current status. Rev. Infect. Dis. 11:S579-S585.
27. Nussenzweig, V., and R. S. Nussenzweig. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283-334.
28. Ozaki, L. S., P. Svec, R. S. Nussenzweig, V. Nussenzweig, and G. N. Godson. 1983. Structure of the Plasmodium knowlesi gene coding for the circumsporozoite protein. Cell 34:815-822.
29. Reed, R. C., V. Louis Wileman, R. L. Wells, A. F. Verheul, R. L. Hunter, and A. A. Lal. 1996. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection. Vaccine 14:828-836.
30. Sherwood, J. A., R. S. Copeland, K. A. Taylor, K. Abok, A. J. Oloo, J. B. Were, G. T. Strickland, D. M. Gordon, W. R. Ballou, J. D. Bales, Jr., R. A. Wirtz, J. Wittes, M. Gross, J. U. Que, S. J. Cryz, C. N. Oster, C. R. Roberts, and J. C. Sadoff. 1996. Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya. Vaccine 14:817-827.
31. Soldati, D., and J. C. Boothroyd. 1993. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science 260:349-352.
32. Soldati, D., and J. C. Boothroyd. 1995. A selector of transcription initiation in the protozoan parasite Toxoplasma gondii. Mol. Cell. Biol. 15:87-93.
33. Stoute, J. A., W. R. Ballou, N. Kolodny, C. D. Deal, R. A. Wirtz, and L. E. Lindler. 1995. Induction of humoral immune response against Plasmodium falciparum sporozoites by immunization with a synthetic peptide mimotope whose sequence was derived from screening a filamentous phage epitope library. Infect. Immun. 63:934-939.
34. Suresh, K., J. W. Mak, and H. S. Yong. 1991. Long term maintenance of Toxoplasma gondii (Rh strain) in Vero cell line and use of harvested antigens for immunodiagnosis. S. E. Asian J. Trop. Med. Pub. Health 22:124-128.
35. Tine, J. A., D. E. Lanar, D. M. Smith, B. T. Wellde, P. Schultheiss, L. A. Ware, E. B. Kauffman, R. A. Wirtz, C. De Taisne, G. S. Hui, S. P. Chang, P. Church, M. R. Hollingdale, D. C. Kaslow, S. Hoffman, K. P. Guito, W. R. Ballou, J. C. Sadoff, and E. Paoletti. 1996. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infect. Immun. 64:3833-3844.
36. Vergara, U., R. Gwadz, D. Schlesinger, V. Nussenzweig, and A. Ferreira. 1985. Multiple non-repeated epitopes on the circumsporozoite protein of Plasmodium knowlesi. Mol. Biochem. Parasitol. 14:283-292.
37. World Health Organization. 1977. Biological substances. International standards, reference preparations, and reference reagents, p. 20-21. World Health Organization, Geneva, Switzerland.